Life Science Practice Success
Larta Institute
is proud of its performance on behalf of Life Science innovations.
These are some of the
results of our dedicated life science practice over the past four years:
- 91 companies have been able to raise over $326+M
in funding
- 3,931 contacts with investors
- 2,895 meetings with investors and partners
- 1,532 CDA’s (Confidentiality Disclosure Agreements)
signed
- 813 Negotiations with investors and partners
- 406 initial proposals and term sheets
- 229 deals
- 7 acquisitions
- 95% of companies cite that the our programs
have made a valuable or major impact in getting their product into the marketplace
- 98% of companies indicated that they would recommend
our programs to others
What Innovators Are Saying
“The understanding
of the investor mentality which I received… (from the program) formed the
basis for presentations made and business plans written. This ultimately
resulted in (a) $2.6 M investment. We would not have obtained the investment
without the attitude adjustment provided by (the program.) (It) pointed me in
the right direction and gave me the initial tools to speak the right language
with investors.”
IA,
Inc/Threefold Sensors
Raised $2.6 million from strategic
investors.
“(The program) provided a valuable platform for new technology presentation,
business networking and investment opportunities. Vivo represents a success
story of the SBIR program i.e. development and commercialization of novel biotechnology
products through an active R&D program and VC funding.”
Vivo Biosciences
Finalized first round $2 million investment
deal
Secured 2 service contracts for cancer drug testing and discovery
Agreement to develop new preclinical bioassay systems and test drug candidates
“It takes time to build up momentum and credibility with potential strategic
partners. Our efforts have finally paid off, and I believe that we will
sign 1 or 2 major agreements within the next 30-60 days. The lessons learned
in (the program) gave us a foundation that we could build upon. Even though
there may no longer be a direct influence in day to day activities, the general
knowledge learned got us started and is still very important in helping us to
continue to make progress.”
Zycare, Inc.
Due diligence begun with 2 potential strategic partners
Company expects revenue to increase at least 10 fold this year
Raised $750K in angel funding in May 2007